Mediastinal bulky tumour in Hodgkin's disease and prognostic value of positron emission tomography in the evaluation of post-treatment residual masses

Katalin Keresztes, Zsolt Lengyel, Katalin Devenyi, Györgyi Vadasz, Zsofia Miltenyi, Arpad Illes

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Among the 193 patients (82 female, 111 male) treated primarily for Hodgkin's disease at our clinic between 1990 and 2001 and followed up until 2003, 42 (22%) had mediastinal bulky tumours (MBTs) by the Cotswolds criteria. The rate of MBT diagnosis was significantly greater in the early stage of the disease, these patients were younger and - in contrast to the other group - they all received combined therapy. No significant differences were found in the overall and relapse-free survival rate in the two groups, but relapse and death rates were lower in the patients with bulky tumours. Of the total number of patients, 27 underwent a total of 31 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) examinations, mainly for the evaluation of post-treatment residual mass viability. In the 12 positive cases, the majority of patients received further therapy. During the mean follow-up time of 58 months (range 5-98 months) after obtaining negative results, progression of the disease was found in 2 cases 14 and 23 months later, respectively. Based on our results, we conclude that FDG-PET examinations show a good correlation with clinical follow-up results.

Original languageEnglish
Pages (from-to)194-199
Number of pages6
JournalActa Haematologica
Volume112
Issue number4
DOIs
Publication statusPublished - 2004

Fingerprint

Hodgkin Disease
Positron-Emission Tomography
Neoplasms
Therapeutics
Recurrence
Fluorodeoxyglucose F18
Disease Progression
Survival Rate
Mortality

Keywords

  • Hodgkin's disease
  • Mediastinal neoplasms
  • Positron emission tomography

ASJC Scopus subject areas

  • Hematology

Cite this

Mediastinal bulky tumour in Hodgkin's disease and prognostic value of positron emission tomography in the evaluation of post-treatment residual masses. / Keresztes, Katalin; Lengyel, Zsolt; Devenyi, Katalin; Vadasz, Györgyi; Miltenyi, Zsofia; Illes, Arpad.

In: Acta Haematologica, Vol. 112, No. 4, 2004, p. 194-199.

Research output: Contribution to journalArticle

@article{9ecc89fa94e44340aa15e5145f4f2823,
title = "Mediastinal bulky tumour in Hodgkin's disease and prognostic value of positron emission tomography in the evaluation of post-treatment residual masses",
abstract = "Among the 193 patients (82 female, 111 male) treated primarily for Hodgkin's disease at our clinic between 1990 and 2001 and followed up until 2003, 42 (22{\%}) had mediastinal bulky tumours (MBTs) by the Cotswolds criteria. The rate of MBT diagnosis was significantly greater in the early stage of the disease, these patients were younger and - in contrast to the other group - they all received combined therapy. No significant differences were found in the overall and relapse-free survival rate in the two groups, but relapse and death rates were lower in the patients with bulky tumours. Of the total number of patients, 27 underwent a total of 31 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) examinations, mainly for the evaluation of post-treatment residual mass viability. In the 12 positive cases, the majority of patients received further therapy. During the mean follow-up time of 58 months (range 5-98 months) after obtaining negative results, progression of the disease was found in 2 cases 14 and 23 months later, respectively. Based on our results, we conclude that FDG-PET examinations show a good correlation with clinical follow-up results.",
keywords = "Hodgkin's disease, Mediastinal neoplasms, Positron emission tomography",
author = "Katalin Keresztes and Zsolt Lengyel and Katalin Devenyi and Gy{\"o}rgyi Vadasz and Zsofia Miltenyi and Arpad Illes",
year = "2004",
doi = "10.1159/000081271",
language = "English",
volume = "112",
pages = "194--199",
journal = "Acta Haematologica",
issn = "0001-5792",
publisher = "S. Karger AG",
number = "4",

}

TY - JOUR

T1 - Mediastinal bulky tumour in Hodgkin's disease and prognostic value of positron emission tomography in the evaluation of post-treatment residual masses

AU - Keresztes, Katalin

AU - Lengyel, Zsolt

AU - Devenyi, Katalin

AU - Vadasz, Györgyi

AU - Miltenyi, Zsofia

AU - Illes, Arpad

PY - 2004

Y1 - 2004

N2 - Among the 193 patients (82 female, 111 male) treated primarily for Hodgkin's disease at our clinic between 1990 and 2001 and followed up until 2003, 42 (22%) had mediastinal bulky tumours (MBTs) by the Cotswolds criteria. The rate of MBT diagnosis was significantly greater in the early stage of the disease, these patients were younger and - in contrast to the other group - they all received combined therapy. No significant differences were found in the overall and relapse-free survival rate in the two groups, but relapse and death rates were lower in the patients with bulky tumours. Of the total number of patients, 27 underwent a total of 31 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) examinations, mainly for the evaluation of post-treatment residual mass viability. In the 12 positive cases, the majority of patients received further therapy. During the mean follow-up time of 58 months (range 5-98 months) after obtaining negative results, progression of the disease was found in 2 cases 14 and 23 months later, respectively. Based on our results, we conclude that FDG-PET examinations show a good correlation with clinical follow-up results.

AB - Among the 193 patients (82 female, 111 male) treated primarily for Hodgkin's disease at our clinic between 1990 and 2001 and followed up until 2003, 42 (22%) had mediastinal bulky tumours (MBTs) by the Cotswolds criteria. The rate of MBT diagnosis was significantly greater in the early stage of the disease, these patients were younger and - in contrast to the other group - they all received combined therapy. No significant differences were found in the overall and relapse-free survival rate in the two groups, but relapse and death rates were lower in the patients with bulky tumours. Of the total number of patients, 27 underwent a total of 31 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) examinations, mainly for the evaluation of post-treatment residual mass viability. In the 12 positive cases, the majority of patients received further therapy. During the mean follow-up time of 58 months (range 5-98 months) after obtaining negative results, progression of the disease was found in 2 cases 14 and 23 months later, respectively. Based on our results, we conclude that FDG-PET examinations show a good correlation with clinical follow-up results.

KW - Hodgkin's disease

KW - Mediastinal neoplasms

KW - Positron emission tomography

UR - http://www.scopus.com/inward/record.url?scp=9144226489&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9144226489&partnerID=8YFLogxK

U2 - 10.1159/000081271

DO - 10.1159/000081271

M3 - Article

C2 - 15564730

AN - SCOPUS:9144226489

VL - 112

SP - 194

EP - 199

JO - Acta Haematologica

JF - Acta Haematologica

SN - 0001-5792

IS - 4

ER -